KushCo Holdings (KSHB) Makes a Move from OTC Markets to List on NASDAQ

With increased cannabis legalization and usage in the United States and Canada, North American companies are striving to seek more recognition on the stock market.

Yesterday, KushCo Holdings Inc., an auxiliary cannabis producer, officially filed to move over to NASDAQ from the OTC markets.

As KushCo awaits a decision on the filing and navigating through the approval process, it will start trading on the OTCQX.

Higher-end market trading has been a big milestone for both U.S. and Canadian entities over the last year as they look for new opportunities for fundraising and a bigger market share.

Organigram Holdings Inc., a new Brunswich-based medical marijuana company, was approved for listing on NASDAQ in May, while Aphira listed on the NYSE in November 2018.

Talking about the planned move to quit the OTC markets, KushCo Chief Executive Officer said that listing on NASDAQ is the most prestigious and highest NASDAQ tier, and this will raise the profile of the company by diversifying their shareholder base and enhancing share liquidity in support of the company’s long-term goals.

Other than selling vape oils and dried flowers to consumers directly, KushCo mainly focusses on offering peripheral products and providing services to other cannabis companies.

KushCo entered the CBD market by partnering with marketing company C.A. Fortune.

As mom and pop CBD stores open up across the country, hemp-based products are also increasingly sprouting in traditional retail locations like convenience stores and pharmacy chains.

Under the new terms of the partnership, KushCo and C.A. Fortune will help client companies in producing CBD products at scale and releasing the products through a vast range of U.S. retail outlets.

In other news, KushCo opened a big Midwest distribution facility last June in Taylor, Michigan. The 40,000 sq. Ft. facility is meant to house, package, and distribute the company’s products in several states. This facility will also have a showroom/ sampling area and a new office space.

Denis Mariti

Denis is one of the most experienced researchers for reviews we have with years of experience in writing about CBD products. He will be one of the most viewed authors due to his own thrill in sharing what he is learning about cannabidiol and supplement use. With a goal of providing clarity within the budding CBD oil industry, Denis will be spending much of the year going through a catalogue of cannabis oil companies in the near future.

Share

Recent Posts

  • Gummies

Condor CBD Gummies – Shocking Customer Scam Concerns?

The Condor CBD Gummies have been the talk of the hemp-derived cannabidiol edibles as of…

2 years ago
  • Guides

Best Delta 8 THC Products – And Why You Need To Try Them

Delta 8 THC is a naturally occurring cannabinoid commonly produced from hemp-derived CBD. It’s relatively…

3 years ago
  • Guides

VidaCap: What To Know About the Best Mushroom Supplements Brand

With more people turning towards natural remedies in recent years, mushroom supplements have taken the…

3 years ago
  • Topicals & Salves

Circle Labs CBD: Legit Hemp Pain Relief Balm That Works?

The Circle Labs CBD Balm is extracted using a cold-infusion process and is an effective…

3 years ago
  • Gummies

Kara’s Orchards CBD Gummies: Safe Full Spectrum Hemp Extract

If anyone is looking for a CBD supplement that is packed with all the necessary…

3 years ago
  • Tinctures & Drops

Sage Elixir CBD: Legit Sage Elixir CBD Oil Tincture or Not?

If anyone has been searching the internet for all the benefits of CBD and where…

3 years ago